SG11201601488VA - Host cell modification with artificial endosymbionts - Google Patents
Host cell modification with artificial endosymbiontsInfo
- Publication number
- SG11201601488VA SG11201601488VA SG11201601488VA SG11201601488VA SG11201601488VA SG 11201601488V A SG11201601488V A SG 11201601488VA SG 11201601488V A SG11201601488V A SG 11201601488VA SG 11201601488V A SG11201601488V A SG 11201601488VA SG 11201601488V A SG11201601488V A SG 11201601488VA
- Authority
- SG
- Singapore
- Prior art keywords
- host cell
- cell modification
- artificial endosymbionts
- endosymbionts
- artificial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361873308P | 2013-09-03 | 2013-09-03 | |
| PCT/US2014/053954 WO2015034962A1 (en) | 2013-09-03 | 2014-09-03 | Host cell modification with artificial endosymbionts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201601488VA true SG11201601488VA (en) | 2016-03-30 |
Family
ID=52583776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201601488VA SG11201601488VA (en) | 2013-09-03 | 2014-09-03 | Host cell modification with artificial endosymbionts |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US9481869B2 (en) |
| EP (1) | EP3041933A4 (en) |
| JP (1) | JP2016528928A (en) |
| KR (1) | KR20160048108A (en) |
| CN (1) | CN106164268A (en) |
| AU (1) | AU2014315321A1 (en) |
| CA (1) | CA2923177A1 (en) |
| IL (1) | IL244016A0 (en) |
| SG (1) | SG11201601488VA (en) |
| WO (1) | WO2015034962A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8956873B2 (en) | 2012-01-13 | 2015-02-17 | Bell Biosystems, Inc. | Host cells with artificial endosymbionts |
| US8828681B2 (en) | 2012-01-13 | 2014-09-09 | Bell Biosystems, Inc. | Host cells with artificial endosymbionts |
| US10076579B2 (en) | 2012-01-13 | 2018-09-18 | Bell Biosystems, Inc. | Host cells with artificial endosymbionts |
| US9023612B2 (en) | 2012-01-13 | 2015-05-05 | Bell Biosystems, Inc. | Eukaryotic cells with artificial endosymbionts for multimodal detection |
| WO2014145785A1 (en) | 2013-03-15 | 2014-09-18 | Bell Biosystems, Llc | Host cells with artificial endosymbionts |
| SG11201601488VA (en) | 2013-09-03 | 2016-03-30 | Bell Biosystems Inc | Host cell modification with artificial endosymbionts |
| US9580758B2 (en) | 2013-11-12 | 2017-02-28 | Luc Montagnier | System and method for the detection and treatment of infection by a microbial agent associated with HIV infection |
| WO2015123409A1 (en) * | 2014-02-13 | 2015-08-20 | Bell Biosystems, Inc. | Systems for making host cells with artificial endosymbionts |
| WO2016054298A1 (en) * | 2014-10-01 | 2016-04-07 | Bell Biosystems, Inc. | Magnetogenetics |
| JP2020000167A (en) * | 2018-06-29 | 2020-01-09 | 国立大学法人広島大学 | Method for producing itaconic acid using psychrophile |
| CN110229762A (en) * | 2019-03-04 | 2019-09-13 | 西北大学 | One plant has the hydrogen-oxidizing bacterium of Plant growth promotion and its is separately cultured and applies |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4385119A (en) | 1980-03-27 | 1983-05-24 | Biomagnetech Corp. | Magnetic bacteria and products derived therefrom |
| US4677067A (en) | 1984-06-22 | 1987-06-30 | Bio-Magnetech Corporation | Magnetotactic bacteria in clinical assay, immunoassay, and cell separation procedures and the like |
| JPS62275679A (en) | 1986-05-23 | 1987-11-30 | Tdk Corp | Preparation of cell containing fine magnetic particle |
| US5843643A (en) | 1992-02-21 | 1998-12-01 | Ratner; Paul L. | Site-specific transfection of eukaryotic cells using polypeptide-linked recombinant nucleic acid |
| US6436694B1 (en) | 1998-01-09 | 2002-08-20 | Cubist Pharmaceuticals, Inc. | Regulable gene expression in gram-positive bacteria |
| AU3277199A (en) | 1998-03-12 | 1999-09-27 | Isao Karube | Techniques for piercing specific site of cell |
| US6004815A (en) | 1998-08-13 | 1999-12-21 | The Regents Of The University Of California | Bacteria expressing nonsecreted cytolysin as intracellular microbial delivery vehicles to eukaryotic cells |
| US8406498B2 (en) | 1999-01-25 | 2013-03-26 | Amnis Corporation | Blood and cell analysis using an imaging flow cytometer |
| US20020012698A1 (en) | 1999-09-01 | 2002-01-31 | Edmund Bauerlein | Magnetosomes, method for making and using |
| EP1281767A3 (en) * | 2001-07-31 | 2003-05-28 | Aladar A. Szalay | Light emitting microorganisms and cells for diagnosis and therapy of tumors |
| GB0121126D0 (en) | 2001-08-31 | 2001-10-24 | Univ Nottingham | Systemic non-nodular endosymbiotic nitrogen fixation in plants |
| WO2004035776A1 (en) | 2002-10-16 | 2004-04-29 | Universal Bio Research Co., Ltd. | Apparatus for introducing biological material, method of introducing biological material and magnetic support for introducing biological material |
| SG179291A1 (en) | 2003-06-18 | 2012-04-27 | Genelux Corp | Modified recombinant vaccinia viruses and other microorganisms, uses thereof |
| US7390646B2 (en) * | 2003-09-17 | 2008-06-24 | The Regents Of The University Of California | Bacterial vectors and methods of use thereof |
| GB0329310D0 (en) | 2003-12-18 | 2004-01-21 | Univ Keele | Method |
| EP1655370A1 (en) | 2004-11-05 | 2006-05-10 | Gesellschaft für Biotechnologische Forschung | Bacterial vector |
| WO2006119102A1 (en) * | 2005-04-29 | 2006-11-09 | Emory University | Methods and compositions for the production and use of magnetosomes |
| US20090325258A1 (en) | 2005-06-03 | 2009-12-31 | Tokyo University Of Agriculture And Technology | Magnetic particle holding carrier and method for preparing the same |
| EP1919507A2 (en) | 2005-08-04 | 2008-05-14 | Thomas William Rademacher | Nanoparticles comprising antibacterial ligands |
| WO2007112107A2 (en) | 2006-03-24 | 2007-10-04 | Gencia Corporation | Synthetic lipid rafts and methods of use |
| AU2007314614A1 (en) | 2006-04-14 | 2008-05-08 | Celsense, Inc. | Methods for assessing cell labeling |
| WO2007140617A1 (en) | 2006-06-08 | 2007-12-13 | Multi-Magnetics Incorporated | Magnetosome gene expression in eukaryotic cells |
| US8361437B2 (en) | 2007-08-28 | 2013-01-29 | University Of Florida Research Foundation, Inc. | Multimodal nanoparticles for non-invasive bio-imaging |
| DE102008049771A1 (en) | 2008-09-30 | 2010-04-08 | Siemens Aktiengesellschaft | Combined Magnetic Resonance Imaging and Guidance Device for Magnetic Particles |
| US20100135912A1 (en) * | 2008-12-02 | 2010-06-03 | Gambhir Sanjiv S | Magnetotactic bacteria mri positive contrast enhancement agent and methods of use |
| WO2010111409A2 (en) | 2009-03-25 | 2010-09-30 | The Salk Institute For Biological Studies | Pluripotent stem cells |
| GB0905331D0 (en) | 2009-03-27 | 2009-05-13 | Avecia Biolog Ltd | Expression process |
| FR2948125B1 (en) | 2009-07-17 | 2011-08-26 | Zoran Dermanovic | METHODS FOR ESTABLISHING SYMBIOSES |
| WO2011011568A2 (en) | 2009-07-24 | 2011-01-27 | The Regenst Of The University Of California | Methods and compositions for the production of fatty acids in photosynthetic prokaryotic microorganisms |
| EP2370085B1 (en) | 2009-11-18 | 2015-04-15 | Nanobacterie | Treatment of cancer or tumor induced by the release of heat generated by various chains of magnetosomes extracted from magnetotactic bacteria and submitted to an alternative magnetic field |
| US8617888B2 (en) * | 2010-07-23 | 2013-12-31 | University Of Florida Research Foundation, Inc. | Bacterial mediated delivery of nuclear protein into pluripotent and differentiated cells |
| US9023612B2 (en) * | 2012-01-13 | 2015-05-05 | Bell Biosystems, Inc. | Eukaryotic cells with artificial endosymbionts for multimodal detection |
| US8828681B2 (en) | 2012-01-13 | 2014-09-09 | Bell Biosystems, Inc. | Host cells with artificial endosymbionts |
| US8956873B2 (en) * | 2012-01-13 | 2015-02-17 | Bell Biosystems, Inc. | Host cells with artificial endosymbionts |
| US9387264B2 (en) | 2012-04-05 | 2016-07-12 | Yeda Research And Development Co. Ltd. | Reporter genes for magnetic resonance imaging and methods of use thereof |
| BR112015005011A2 (en) | 2012-09-07 | 2018-04-17 | Genentech Inc | methods and compositions for producing induced hepatocytes. |
| WO2014145785A1 (en) * | 2013-03-15 | 2014-09-18 | Bell Biosystems, Llc | Host cells with artificial endosymbionts |
| SG11201601488VA (en) | 2013-09-03 | 2016-03-30 | Bell Biosystems Inc | Host cell modification with artificial endosymbionts |
| WO2015123409A1 (en) * | 2014-02-13 | 2015-08-20 | Bell Biosystems, Inc. | Systems for making host cells with artificial endosymbionts |
-
2014
- 2014-09-03 SG SG11201601488VA patent/SG11201601488VA/en unknown
- 2014-09-03 KR KR1020167006754A patent/KR20160048108A/en not_active Application Discontinuation
- 2014-09-03 CA CA2923177A patent/CA2923177A1/en not_active Abandoned
- 2014-09-03 AU AU2014315321A patent/AU2014315321A1/en not_active Abandoned
- 2014-09-03 WO PCT/US2014/053954 patent/WO2015034962A1/en active Application Filing
- 2014-09-03 EP EP14842177.9A patent/EP3041933A4/en not_active Ceased
- 2014-09-03 JP JP2016540360A patent/JP2016528928A/en active Pending
- 2014-09-03 CN CN201480054264.3A patent/CN106164268A/en active Pending
- 2014-09-03 US US14/476,584 patent/US9481869B2/en not_active Expired - Fee Related
-
2016
- 2016-02-08 IL IL244016A patent/IL244016A0/en unknown
- 2016-10-22 US US15/331,847 patent/US9752129B2/en not_active Expired - Fee Related
-
2017
- 2017-09-01 US US15/694,085 patent/US10184114B2/en not_active Expired - Fee Related
-
2018
- 2018-12-19 US US16/225,610 patent/US20190112581A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2014315321A1 (en) | 2016-03-03 |
| EP3041933A1 (en) | 2016-07-13 |
| JP2016528928A (en) | 2016-09-23 |
| US20170362576A1 (en) | 2017-12-21 |
| EP3041933A4 (en) | 2017-04-26 |
| WO2015034962A1 (en) | 2015-03-12 |
| WO2015034962A8 (en) | 2016-04-21 |
| US10184114B2 (en) | 2019-01-22 |
| CA2923177A1 (en) | 2015-03-12 |
| IL244016A0 (en) | 2016-04-21 |
| CN106164268A (en) | 2016-11-23 |
| US9752129B2 (en) | 2017-09-05 |
| US20170037378A1 (en) | 2017-02-09 |
| US20150064787A1 (en) | 2015-03-05 |
| US20190112581A1 (en) | 2019-04-18 |
| KR20160048108A (en) | 2016-05-03 |
| US9481869B2 (en) | 2016-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1223554A1 (en) | Cell | |
| IL244016A0 (en) | Host cell modification with artificial endosymbionts | |
| AU356417S (en) | Battery | |
| EP3033769A4 (en) | Memory cell with independently-sized elements | |
| HK1200014A1 (en) | Host cells with artificial endosymbionts | |
| EP2945204A4 (en) | Battery case | |
| EP2988346A4 (en) | Cell case | |
| GB201303814D0 (en) | Battery structure | |
| HK1212578A1 (en) | Implantable device with bridge | |
| EP3067906A4 (en) | Electrochemical device | |
| EP3018750A4 (en) | Cell | |
| GB201319087D0 (en) | Artificial airway device | |
| IL247044A0 (en) | Systems for making host cells with artificial endosymbionts | |
| GB201312332D0 (en) | Cell locations | |
| GB201310031D0 (en) | Cell | |
| EP2953200A4 (en) | Battery | |
| EP3038195A4 (en) | Lithium cell | |
| GB201309576D0 (en) | Nuclear battery | |
| GB2510813B (en) | Letter-plate with fluid-damped hinges | |
| GB201312803D0 (en) | Cell component | |
| GB201301952D0 (en) | Electrochemical cells | |
| GB201320573D0 (en) | T Cell | |
| GB201317589D0 (en) | Cell | |
| AU2013903873A0 (en) | Battery Reader | |
| GB201317735D0 (en) | Solar sphere |